Literature DB >> 25951497

miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications.

Marco Ragusa1, Cristina Barbagallo1, Luisa Statello1, Rosario Caltabiano2, Andrea Russo3, Lidia Puzzo2, Teresio Avitabile3, Antonio Longo3, Mario D Toro3, Davide Barbagallo1, Hadi Valadi4, Cinzia Di Pietro1, Michele Purrello1, Michele Reibaldi3.   

Abstract

Uveal melanoma (UM) represents approximately 5-6% of all melanoma diagnoses and up to 50% of patients succumb to their disease. Although several methods are available, accurate diagnosis is not always easily feasible because of potential accidents (e.g., intraocular hemorrhage). Based on the assumption that the profile of circulating miRNAs is often altered in human cancers, we verified whether UM patients showed different vitreous humor (VH) or serum miRNA profiles with respect to healthy controls. By using TaqMan Low Density Arrays, we analyzed 754 miRNAs from VH, vitreal exosomes, and serum of 6 UM patients and 6 healthy donors: our data demonstrated that the UM VH profile was unique and only partially overlapping with that from serum of the same patients. Whereas, 90% of miRNAs were shared between VH and vitreal exosomes, and their alterations in UM were statistically overlapped with those of VH and vitreal exosomes, suggesting that VH alterations could result from exosomal dysregulation. We report 32 miRNAs differentially expressed in UM patients in at least 2 different types of samples analyzed. We validated these data on an independent cohort of 12 UM patients. Most alterations were common to VH and vitreal exosomes (e.g., upregulation of miR-21,-34 a,-146a). Interestingly, miR-146a was upregulated in the serum of UM patients, as well as in serum exosomes. Upregulation of miR-21 and miR-146a was also detected in formalin-fixed, paraffin-embedded UM, suggesting that VH or serum alterations in UM could be the consequence of disregulation arising from tumoral cells. Our findings suggest the possibility to detect in VH and serum of UM patients "diagnostic" miRNAs released by the affected eye: based on this, miR-146a could be considered a potential circulating marker of UM.

Entities:  

Keywords:  exosomes, microRNAs, serum, uveal melanoma, vitreous humor

Mesh:

Substances:

Year:  2015        PMID: 25951497      PMCID: PMC4622662          DOI: 10.1080/15384047.2015.1046021

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  48 in total

1.  Incidence of noncutaneous melanomas in the U.S.

Authors:  Colleen C McLaughlin; Xiao-Cheng Wu; Ahmedin Jemal; Howard J Martin; Lisa M Roche; Vivien W Chen
Journal:  Cancer       Date:  2005-03-01       Impact factor: 6.860

Review 2.  Recent developments in prognostic and predictive testing in uveal melanoma.

Authors:  Matthew G Field; J William Harbour
Journal:  Curr Opin Ophthalmol       Date:  2014-05       Impact factor: 3.761

3.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

4.  Very long-term prognosis of patients with malignant uveal melanoma.

Authors:  Emma Kujala; Teemu Mäkitie; Tero Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

5.  Survival rates with uveal melanoma in the United States: 1973-1997.

Authors:  Arun D Singh; Allan Topham
Journal:  Ophthalmology       Date:  2003-05       Impact factor: 12.079

Review 6.  Adding fuel to fire: microRNAs as a new class of mediators of inflammation.

Authors:  F J Sheedy; L A J O'Neill
Journal:  Ann Rheum Dis       Date:  2008-12       Impact factor: 19.103

7.  Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease.

Authors:  Susan Achberger; Wayne Aldrich; Raymond Tubbs; John W Crabb; Arun D Singh; Pierre L Triozzi
Journal:  Mol Immunol       Date:  2013-12-25       Impact factor: 4.407

8.  Identifying mRNA, microRNA and protein profiles of melanoma exosomes.

Authors:  Deyi Xiao; Joanna Ohlendorf; Yinlu Chen; Douglas D Taylor; Shesh N Rai; Sabine Waigel; Wolfgang Zacharias; Hongying Hao; Kelly M McMasters
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

9.  Highly skewed distribution of miRNAs and proteins between colorectal cancer cells and their exosomes following Cetuximab treatment: biomolecular, genetic and translational implications.

Authors:  Marco Ragusa; Luisa Statello; Marco Maugeri; Cristina Barbagallo; Roberta Passanisi; Mohamed S Alhamdani; Giovanni Li Destri; Alessandro Cappellani; Davide Barbagallo; Marina Scalia; Hadi Valadi; Jörg D Hoheisel; Cinzia Di Pietro; Michele Purrello
Journal:  Oncoscience       Date:  2014-03-16

10.  Serum microRNAs are promising novel biomarkers.

Authors:  Shlomit Gilad; Eti Meiri; Yariv Yogev; Sima Benjamin; Danit Lebanony; Noga Yerushalmi; Hila Benjamin; Michal Kushnir; Hila Cholakh; Nir Melamed; Zvi Bentwich; Moshe Hod; Yaron Goren; Ayelet Chajut
Journal:  PLoS One       Date:  2008-09-05       Impact factor: 3.240

View more
  58 in total

Review 1.  The choice of endogenous controls in exosomal microRNA assessments from biofluids.

Authors:  G Occhipinti; M Giulietti; G Principato; F Piva
Journal:  Tumour Biol       Date:  2016-07-20

Review 2.  Emerging roles of microRNAs and their implications in uveal melanoma.

Authors:  Chun Yang; Yuejiao Wang; Pierre Hardy
Journal:  Cell Mol Life Sci       Date:  2020-08-11       Impact factor: 9.261

3.  miR-337 can be a key negative regulator in melanoma.

Authors:  Wanan Xiao; Enyang Yao; Wei Zheng; Feng Tian; Lijie Tian
Journal:  Cancer Biol Ther       Date:  2017-05-12       Impact factor: 4.742

Review 4.  Roles of exosomes in the normal and diseased eye.

Authors:  Mikael Klingeborn; W Michael Dismuke; Catherine Bowes Rickman; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2017-04-29       Impact factor: 21.198

Review 5.  MicroRNAs in extracellular vesicles: potential cancer biomarkers.

Authors:  Takashi Kinoshita; Kenneth W Yip; Tara Spence; Fei-Fei Liu
Journal:  J Hum Genet       Date:  2016-07-07       Impact factor: 3.172

6.  Biomarkers for Nonexudative Age-Related Macular Degeneration and Relevance for Clinical Trials: A Systematic Review.

Authors:  Vivienne Fang; Maria Gomez-Caraballo; Eleonora M Lad
Journal:  Mol Diagn Ther       Date:  2021-08-25       Impact factor: 4.074

Review 7.  Multiplex protein analysis for the study of glaucoma.

Authors:  Gülgün Tezel
Journal:  Expert Rev Proteomics       Date:  2021-10-29       Impact factor: 3.940

Review 8.  Emerging Biomarkers in Cutaneous Melanoma.

Authors:  Anna Eisenstein; Estela Chen Gonzalez; Rekha Raghunathan; Xixi Xu; Muzhou Wu; Emily O McLean; Jean McGee; Byungwoo Ryu; Rhoda M Alani
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

Review 9.  Non-coding landscapes of colorectal cancer.

Authors:  Marco Ragusa; Cristina Barbagallo; Luisa Statello; Angelo Giuseppe Condorelli; Rosalia Battaglia; Lucia Tamburello; Davide Barbagallo; Cinzia Di Pietro; Michele Purrello
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 10.  Liquid Biopsy in Uveal Melanoma: Are We There Yet?

Authors:  Eva Jin; Julia V Burnier
Journal:  Ocul Oncol Pathol       Date:  2020-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.